BIO-KEY INTERNATIONAL ($BKYI) posted quarterly earnings results for Q1 2026 on Monday, May 18th. The company reported earnings of -$0.15 per share, beating estimates of -$0.61 by $0.46. The company also reported revenue of $2,150,000, missing estimates of $2,244,000 by $-94,000.
You can see Quiver Quantitative's $BKYI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIO-KEY INTERNATIONAL Hedge Fund Activity
We have seen 5 institutional investors add shares of BIO-KEY INTERNATIONAL stock to their portfolio, and 14 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITIGROUP INC added 50,338 shares (+457618.2%) to their portfolio in Q1 2026, for an estimated $26,684
- JANE STREET GROUP, LLC removed 25,317 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $13,420
- RENAISSANCE TECHNOLOGIES LLC removed 20,484 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,042
- GEODE CAPITAL MANAGEMENT, LLC removed 19,349 shares (-39.6%) from their portfolio in Q1 2026, for an estimated $10,256
- XTX TOPCO LTD removed 18,829 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,150
- UBS GROUP AG removed 14,721 shares (-96.4%) from their portfolio in Q1 2026, for an estimated $7,803
- FLOW TRADERS U.S. LLC removed 11,273 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,975
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
